Twinrix should not be administered to subjects with known hypersensitivity to any constituent of the vaccine, or to subjects having shown signs of hypersensitivity after previous administration of Twinrix or the monovalent hepatitis A or hepatitis B vaccines or to subjects allergic to Neomycin.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
